Despite recent strong advances in heart failure (HF) treatment, mainly in pharmacology and
devices, as well as HF monitoring, patients with HF still suffer from a high burden in quality of …

Although there have been important successes in the development of therapies for chronic
heart failure (HF) in recent decades, most recent HF trials have failed to show added benefit …

Heart failure (HF) is a complex clinical syndrome that results from any structural or functional
impairment of ventricular filling or ejection of blood. Classified based on left ventricular (LV) …

Background: Sleep-disordered breathing (SDB) has been reported to influence mortality and
occurrence of ventricular tachyarrhythmia in patients with chronic heart failure (CHF). It …

The prevalence of sleep-disordered breathing (SDB) in the general population is 2% to 4%,
1 in contrast SDB is much more common in patients with heart failure (HF), with the …

Sleep-disordered breathing (SDB) is the most common comorbidity in patients with heart
failure (HF) and has a significant impact on quality of life, morbidity, and mortality. A number …

The prevalence and characteristics of sleep-disordered breathing (SDB) in patients with
ventricular arrhythmias, such as premature ventricular complexes and ventricular …

Heart failure is a growing problem, placing an increasing burden on public health resources
and continuing to exert a high toll in mortality and morbidity. Sleep disordered breathing …

Abstract Sleep-disordered breathing (SDB), either obstructive sleep apnoea (OSA) or central
sleep apnoea (CSA)/Cheyne-Stokes respiration (CSR) and often a combination of the two, is …

Background The prevalence of sleep‐disordered breathing (SDB) is closely related to the
severity of heart failure (HF), and the severity of HF is different in patients with HF of different …